Related Experiment Videos

Inhibition of neointimal formation in porcine coronary artery by a Ras mutant

C H Wu1, C S Lin, J S Hung

  • 1School of Medicine, China Medical College, Taiwan.

Abstract

Insights

A novel gene therapy using AdRasN17 significantly reduced neointimal hyperplasia after balloon injury in pig coronary arteries. This approach shows promise for preventing restenosis in human cardiovascular disease.

Area of Science:

  • Cardiovascular Research
  • Gene Therapy
  • Vascular Biology

Background:

  • Restenosis after balloon angioplasty is a significant clinical challenge.
  • Current experimental models, like the rat carotid artery, may not accurately reflect human coronary artery responses.
  • There is a need for more relevant animal models to study restenosis prevention strategies.

Purpose of the Study:

  • To evaluate the efficacy of virus-mediated dominant negative mutant RasN17 (AdRasN17) in preventing balloon injury-induced restenosis.
  • To utilize pig coronary arteries as a more relevant preclinical model for human cardiovascular responses.
  • To assess the therapeutic potential of AdRasN17 gene delivery in a large animal model.

Main Methods:

  • Pig coronary arteries were subjected to balloon injury.
  • Viral particles (AdRasN17 or AdLacZ control) were delivered via a dispatch catheter to the injured segment.
  • Histological analysis was performed six weeks post-injury to assess neointimal formation and lumen size.

Main Results:

  • Balloon injury induced significant neointimal formation and arterial remodeling.
  • AdRasN17 treatment resulted in a 56% reduction in neointimal hyperplasia compared to the AdLacZ control.
  • The AdRasN17 group exhibited a 75% increase in lumen size, indicating improved vessel patency.

Conclusions:

  • AdRasN17 demonstrates significant therapeutic potential in preventing neointimal formation in pig coronary arteries.
  • This study validates the pig coronary artery model for evaluating restenosis therapies.
  • Virus-mediated gene transfer of AdRasN17 is an effective strategy against balloon injury-induced vascular remodeling.

Related Concept Videos